Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Ricklin, D

Class:Id	Person:2314509
_displayName	Ricklin, D
_timestamp	2012-06-07 14:33:45
created	[InstanceEdit:2314508] Shamovsky, V, 2012-06-07
firstname	Daniel
initial	D
surname	Ricklin
(author)	[LiteratureReference:4339282] Structures of C3b in complex with factors B and D give insight into complement convertase formation [LiteratureReference:4339296] Structure of complement fragment C3b-factor H and implications for host protection by complement regulators [LiteratureReference:4416369] Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b [LiteratureReference:4420260] Interactions between coagulation and complement--their role in inflammation [LiteratureReference:9650298] Novel mechanisms and functions of complement [LiteratureReference:9650302] Complement in immune and inflammatory disorders: pathophysiological mechanisms [LiteratureReference:9957015] From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors [LiteratureReference:9957025] Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention [LiteratureReference:9957039] Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors [LiteratureReference:9957072] Complement-targeted therapeutics: Are we there yet, or just getting started?
[Change default viewing format]

No pathways have been reviewed or authored by Ricklin, D (2314509)